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Abstract
BACKGROUND & AIMS—Positive-sense RNA viruses remodel intracellular membranes to
generate specialized membrane compartments for viral replication. Several RNA viruses,
including poliovirus and hepatitis C virus (HCV), require phosphatidylinositol (PI) 4-kinases for
their replication. However, it is not known how PI 4-kinases and their product, PI(4)P, facilitate
host membrane reorganization and viral replication. Furthermore, although the HCV replication
compartment, known as the membranous web, is believed to be cholesterol-enriched, the
mechanisms by which this occurs have not been elucidated. We aimed to identify and characterize
a PI 4-kinase effector in HCV replication.
METHODS—We used a combination of microscopic and biochemical methods to study HCV
replication, web morphology, the distribution of intracellular protein and PI(4)P, along with
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cholesterol trafficking in HCV-infected cells. PI 4-kinase and oxysterol-binding protein (OSBP)
were inhibited using RNA interference or small molecules in cells expressing a full-length
genotype 1b replicon or infected with the JFH-1 strain of HCV.
RESULTS—OSBP was required for HCV replication and membranous web integrity. OSBP was
recruited to membranous webs in a PI 4-kinase-dependent manner, and both these factors were
found to regulate cholesterol trafficking to the web. We also found OSBP to be required for
poliovirus infection but dispensable for dengue virus.
CONCLUSIONS—OSBP is a PI 4-kinase effector in HCV infection, and contributes to the
integrity and cholesterol enrichment of the membranous web. OSBP might also be a PI 4-kinase
effector in poliovirus infection and could be involved in replication of other viruses that require PI
4-kinases.
Keywords
lipid transfer proteins; phosphatidylinositol 4-phosphate; lipid kinase; viral replication
INTRODUCTION
Positive-sense single-stranded RNA viruses remodel intracellular membranes to generate
specialized membrane compartments for viral replication1, which might facilitate genome
replication and packaging by restricting diffusion, and may shield viral components from
host innate immunity. Hepatitis C virus (HCV) is a positive-sense RNA virus in the family
Flaviviridae. While its genome is initially translated at the host endoplasmic reticulum, RNA
replication occurs in association with virus-induced intracellular membranes termed the
“membranous web”2,3. Although the HCV membranous web is thought to be enriched in
cholesterol4–6, the molecular mechanisms by which this occurs are unknown.
The host phosphatidylinositol 4-kinase PI4KA and its product phosphatidylinositol 4-
phosphate (PI(4)P) are essential for HCV replication7–13 and membranous web
integrity8,9,14–16. Although the related PI 4-kinase PI4KB is essential for the replication of
several other positive-sense RNA viruses17,18, evidence for its importance in HCV infection
is mixed10,11,15. PI4KA requires lipid kinase activity to support HCV replication, suggesting
that PI(4)P is also essential for HCV replication9,15. PI4KA is recruited to the HCV
membranous web by a direct interaction with NS5A, and HCV infection is associated with
increased intracellular PI(4)P levels and enrichment of PI(4)P at the membranous web.
A crucial and as yet unanswered question is how PI 4-kinases and PI(4)P facilitate RNA
virus replication and HCV web integrity. One possibility is that PI(4)P recruits
phosphoinositide-binding proteins to viral replication compartments. In particular,
oxysterol-binding protein (OSBP) is a plausible candidate PI4KA effector in the HCV life
cycle for several reasons. First, OSBP interacts with HCV NS5A, and its silencing inhibits
both infectious particle secretion and replication19,20. Second, OSBP binds to PI(4)P via a
pleckstrin homology (PH) domain at its N-terminus21. Third, OSBP encodes a sterol-
binding domain22 and can mediate PI(4)P-dependent cholesterol transfer between liposomes
in vitro23. However, there has been controversy regarding the role of OSBP-related proteins
WANG et al. Page 2
Gastroenterology. Author manuscript; available in PMC 2015 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(ORPs) in sterol trafficking in yeast24,25, and there has been little direct evidence that OSBP
or ORPs regulate sterol trafficking in mammalian cells.
Herein, we focus on the role of OSBP as a possible effector of PI4KA and PI(4)P in
supporting HCV replication. OSBP is essential not only for the replication of HCV, but also
for the integrity of the HCV membranous web. OSBP is recruited to the membranous web in
HCV-infected cells in a PI(4)P-dependent manner. In addition, we find that OSBP and
PI4KA regulate the transport of cholesterol to the membranous web. Finally, the dependence
of poliovirus and dengue virus replication on OSBP correlates with their PI 4-kinase
dependence, suggesting that OSBP may be a PI 4-kinase effector for multiple RNA viruses.
This study sheds light on how viruses modulate host lipid membrane compositions to their
own benefit by exploiting host phosphoinositide signaling pathways.
Results
OSBP is relevant to HCV replication
To test the role of OSBP in HCV replication, OR6 cells containing a full-length genotype 1b
HCV replicon expressing a Renilla luciferase reporter gene26 were transduced with five
independent shRNA lentiviral vectors targeting OSBP. The magnitude of HCV replication
inhibition correlated with the degree of OSBP silencing (Supplementary Figure 1A). Two
shRNAs that efficiently silenced OSBP significantly inhibited HCV replication and reduced
HCV NS5A protein levels without detectable cytotoxicity in OR6 cells (Figure 1A) as well
as in the genotype 2a JFH-1 infectious HCV system (Figure 1B), indicating that the
dependency of HCV on OSBP is not genotype-specific.
Using an orthogonal pharmacologic approach, we found that the compound OSW-1, which
inhibits OSBP by binding as well as through proteasomal degradation27, inhibited OR6
replication and JFH-1 infection in a dose-dependent manner (IC50 1.37 ± 0.07 nM) with
cytotoxicity only at the highest tested doses (Figure 1C and Supplementary Figure 1B).
To further exclude the possibility that OSBP shRNAs inhibit HCV replication by off-target
effects and to assess the domains of OSBP necessary for HCV replication, we conducted a
rescue assay. OR6 cells stably expressing an shRNA targeting the 3′UTR of the endogenous
OSBP mRNA were transduced with lentiviral vectors encoding OSBP or OSBP mutant
constructs lacking the OSBP 3′UTR. We generated three OSBP mutants: deletion of the
PI(4)P-binding PH domain (ΔPH), a F359A/F360A substitution in the FFAT (two
phenylalanines in an acidic tract) motif that interacts with ER proteins called Vesicle-
Associated Membrane Protein-Associated Proteins (VAPs), and deletion of the steroid-
binding domain (ΔSBD). The inhibition of HCV by knockdown of endogenous OSBP could
be rescued by expression of wild-type OSBP but not by the mutant constructs (Figure 1D),
indicating that the PH domain, FFAT motif, and SBD are all required for OSBP function.
OSBP localizes to NS5A-positive structures in HCV-infected cells
Since OSBP is essential for HCV replication, we hypothesized that OSBP might associate
with HCV membranous webs. In HCV-infected cells, most of the endogenous OSBP was in
a paranuclear distribution consistent with Golgi localization. However, we also observed
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colocalization of viral NS5A with some endogenous OSBP (Figure 2A, Manders’
coefficient M1=0.60 (fraction of NS5A overlapping OSBP); see also Supplementary Figure
2A), suggesting that some OSBP localizes to the membranous web. We used Manders’
coefficients here because they more accurately quantitate partial overlap between two
channels. OSBP-ΔPH, however, no longer appeared to localize to Golgi or NS5A-positive
membranes (Supplementary Figure 2B). In contrast, the OSBP F359A/F360A and OSBP
ΔSBD mutants still showed partial colocalization with NS5A (Supplementary Figure 2B),
suggesting that OSBP localization to NS5A-positive membranes requires the PH domain but
not the FFAT motif or the SBD.
Membrane-associated HCV replicase components are resistant to extraction with cold
NP-40 detergent and exhibit low buoyant densities on density gradient centrifugation4,5,
which are properties of cholesterol-enriched “lipid raft” microdomains. As expected, NS5A
cofractionated with the DRM marker flotilin-1 (Figure 2B). HCV infection was associated
with an increase in DRM-associated OSBP, consistent with our hypothesis that OSBP
associates with membranous webs in HCV-infected cells.
The membranous structure of the HCV replication complex can protect viral and cellular
components from exogenous proteases and nucleases in vitro1,4. We found that a fraction of
NS5A was resistant to proteinase K digestion in the absence of detergent, while NS5A was
completely digested after detergent treatment (Figure 2C). Consistent with our model, HCV
infection was associated with increased amounts of protease-resistant OSBP in the absence
of detergent (Figure 2C).
OSBP is required for membranous web integrity
Silencing or pharmacologic inhibition of PI4KA induces the accumulation of membrane
“clusters” containing HCV NS5A and other viral replication components8,9,14–16, indicating
that PI4KA and its product PI(4)P are required for membranous web integrity. Either PI4KA
or OSBP silencing induced the formation of NS5A-positive membrane clusters in HCV-
infected cells (Figure 3A). Although the efficiency of HCV infection was markedly reduced
by PI4KA or OSBP silencing, a low percentage of stably silenced cells could be infected
with HCV, likely reflecting heterogeneous knockdown. The pharmacologic OSBP inhibitor
OSW-1 also induced membrane cluster formation in JFH-1 infected cells (Figure 3B). To
exclude the possibility that this effect was dependent on inhibition of HCV RNA replication,
we expressed the NS3-5B polyprotein in Huh7.5.1 cells using T7 RNA polymerase that
renders viral protein expression independent of viral replication15, and found similar
membrane clusters in OSBP-silenced cells (Supplementary Figure 3A).
Next, we examined the ultrastructure of the altered membranous webs induced by OSBP and
PI4KA inhibition using electron microscopy. In mock treated cells, JFH-1 infection induced
the formation of double membrane vesicles (DMVs) of somewhat heterogeneous size (mean
diameter 166 ± 49 nm) and morphology, as well as multi-membrane vesicles (MMVs)
(Figure 3C, upper panels), consistent with previous reports28. These DMVs and MMVs
were typically found in the vicinity of lipid droplets (LDs) and were not seen in uninfected
cells (Supplementary Figure 3B). In contrast, DMVs were smaller and more homogeneous
in size (average diameter 76 ± 16 nm) in HCV-infected cells treated with the PI4KA
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inhibitor AL-914. These small DMVs were often aggregated in clusters (Figure 3C and
Supplementary Figure 3B) but were also occasionally dispersed (Supplementary Figure 3B).
These clusters of small DMVs seen by TEM likely correspond to the NS5A-positive clusters
seen by immunofluorescence (Supplementary Figure 3C and 9). Similarly, OSW-1 treatment
was associated with clusters of small, homogenous DMVs with diameters (86±17nm)
(Figure 3C, lower panels) similar to those of AL-9 treated cells, as well as individual small
DMVs adjacent to LDs (Supplementary Figure 3B). In contrast, the NS5B polymerase
inhibitor 2′CMeA did not reduce mean DMV diameter or induce DMV clustering
(Supplementary Figure 3B), indicating that the observed effect of PI4KA/OSBP inhibition
was not a nonspecific result of inhibiting HCV replication.
Collectively, these results indicate that OSBP, like PI4KA, is required for HCV
membranous web integrity. The similar phenotypes of the membrane alterations induced by
OSBP or PI4KA inhibition support the hypothesis that these two host factors function along
the same pathway.
HCV induced PI(4)P increase does not require OSBP and is not sufficient for membranous
web integrity
Intracellular PI(4)P levels are increased by HCV infection both in vitro and in vivo in a
PI4KA-dependent manner9,14,16. We assessed the relative effects of PI4KA or OSBP
silencing on PI(4)P levels in HCV-expressing cells. To avoid confounding effects of PI4KA
and OSBP silencing on HCV replication, this experiment was conducted with Huh7/T7 cells
expressing the NS3-5B/GFP polyprotein described above. PI(4)P was elevated in NS3-
NS5B/GFP expressing cells transduced with a nontargeting shRNA by approximately 3.5-
fold (Figure 4B) as compared to HCV-nonexpressing cells (Figure 4A). As expected, PI4KA
silencing blocked the upregulation of intracellular PI(4)P levels by HCV polyprotein
expression and was also associated with the appearance of NS5A-positive membrane
clusters. In contrast, OSBP silencing did not block the upregulation of intracellular PI(4)P
levels in HCV-expressing cells despite the formation of membrane clusters (Figures 4A and
B), consistent with OSBP functioning downstream of PI4KA and PI(4)P.
HCV expression is associated not only with increased total levels of intracellular PI(4)P but
also with PI(4)P enrichment at the membranous web15–17. In HCV-infected control cells
expressing a nontargeting shRNA, there was substantial NS5A-PI(4)P colocalization (Figure
4C, Pearson’s correlation Pr=0.75). As expected, in PI4KA-silenced cells, we observed less
total intracellular PI(4)P and little colocalization between PI(4)P and NS5A at membrane
clusters (Pr=0.42). In contrast, in OSBP-silenced cells, there was prominent PI(4)P staining
at membrane clusters (Figure 4C; Pr=0.78 and 0.75 for shOSBP-A and shOSBP-B,
respectively).
We conclude from these results that although OSBP is required for membranous web
integrity, PI4KA-mediated PI(4)P accumulation does not require OSBP, and that PI(4)P
upregulation is not sufficient for normal membranous web morphology. These results
suggest that OSBP functions downstream of PI4KA and PI(4)P in membranous web
formation.
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OSBP localization to NS5A-positive structures requires PI4KA activity
Targeting of OSBP to membranes requires its PI(4)P-binding PH domain (21 and
Supplementary Figure 2B). We asked whether OSBP association with NS5A-positive
structures requires PI4KA and PI(4)P. OSBP-NS5A colocalization could be observed in
NS3-NS5B/GFP expressing Huh7/T7 cells transduced with a nontargeting shRNA (Figure
5A), as we had observed in HCV-infected cells (Figure 2A). However, PI4KA silencing
(Figure 5A) or pharmacologic inhibition (Figure 5B) led to the loss of OSBP colocalization
with membrane clusters, indicating that PI4KA and its lipid kinase activity are required for
OSBP recruitment to the membranous web.
PI4KA and OSBP are required for cholesterol trafficking to NS5A-positive, detergent-
resistant membranes
The HCV membranous web is cholesterol-enriched4–6, and cholesterol biosynthesis
inhibitors hamper HCV replication4. To test directly whether cholesterol is required for
HCV replication, OR6 replicon cells were treated with methyl-β-cyclodextrin (MβCD),
which binds to and depletes cholesterol from membranes. MβCD caused a dose-dependent
decrease in replication (Figure 6A, left panel) with little cytotoxicity (Supplementary Figure
4A). This decrease was partially reversed if MβCD was presaturated with cholesterol
(MβCD/CH; Figure 6A, left panel), indicating that MβCD inhibits HCV replication
primarily by cholesterol removal rather than by nonspecific effects. Immunoblotting also
demonstrated a dose-dependent reduction of NS5A expression by MβCD treatment that was
partially reversed by cholesterol presaturation (Figure 6A, right panel). MβCD and MβCD-
cholesterol complexes had the expected effects on cellular cholesterol content (Figure 6A,
middle panel).
OSBP binds to cholesterol in vitro22 and can catalyze the PI(4)P-dependent transfer of
cholesterol between synthetic liposomes23. To test whether cholesterol is transported to
NS5A-positive HCV membranous webs and if so, whether this process requires OSBP, we
labeled JFH-1 infected Huh7.5.1 cells with TopFluor-cholesterol (TF-cholesterol), a
fluorescent cholesterol analog that closely mimics the membrane partitioning and trafficking
of native cholesterol29. TF-cholesterol colocalized extensively with NS5A in nontargeting
shRNA-expressing cells (Figure 6B), suggesting that TF-cholesterol is transported to the
membranous web. In contrast, there was little colocalization between TF-cholesterol and
NS5A in cells silenced for either PI4KA or OSBP, indicating that cholesterol trafficking to
NS5A-positive structures requires both PI4KA and OSBP.
To exclude possible artifacts from cell fixation, we also examined TF-cholesterol transport
to membranous webs in living cells harboring a subgenomic HCV replicon with mCherry-
tagged NS5A. In control cells, TF-cholesterol colocalized extensively with NS5A-positive
membranes (Figure 6C, D). In contrast, treatment with the PI4K inhibitor AL-9 (Figure 6C)
and the OSBP inhibitor OSW-1 (Figure 6D) inhibited transport of cholesterol to NS5A-
positive membrane clusters.
The requirement of PI4KA and OSBP for cholesterol transport to the membranous web was
further tested by a biochemical assay. HCV-infected cells labeled with TF-cholesterol were
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treated with AL-9 or OSW-1 to inhibit PI4KA or OSBP, respectively, and we quantitated
the amount of incorporated TF-cholesterol fluorescence in isolated DRM fractions and in
detergent-soluble membranes. In HCV-infected control cells, an increased proportion of TF-
cholesterol was detected in DRM fractions compared to uninfected cells (Figure 6E, upper
panel), while AL-9 or OSW-1 treatment reduced the proportion of TF-cholesterol found in
DRMs (Figure 6E, lower panel). Brief AL-9 or OSW-1 treatment did not lower the total
amount of NS5A protein (Figure 6E, lower panel inset), and silencing of PI4KA or OSBP
did not significantly block TF-cholesterol cellular uptake (Supplementary Figure 4B). These
results collectively suggest a specific requirement of PI4KA and OSBP for cholesterol
trafficking to DRMs in HCV-infected cells.
OSBP and its yeast homolog, Osh4p, can exchange sterols for PI(4)P between lipid
bilayers30,31. Although Osh4p lacks a PH domain, it interacts with PI(4)P at a binding site
that overlaps with the sterol-binding domain (SBD)30. Several residues at the entrance of the
SBD (including H143/H144 and K336 in Osh4p) form essential contacts with PI(4)P but are
dispensable for sterol binding and transfer activity30, and we mapped the corresponding
residues in OSBP to H522/H523 and K736 (Supplementary Figure 4C). To test whether
these PI(4)P-interacting residues at the OSBP SBD are essential for its ability to support
HCV replication, we conducted a rescue assay. HCV inhibition caused by shRNA targeting
the OSBP 3′UTR could be rescued by exogenous expression of wild type OSBP but not by
the OSBP mutants H522A/H523A or K736A (Figure 6F). Immunostaining showed that
these two OSBP mutants colocalize with NS5A, but fail to transport TF-cholesterol to
NS5A-positive structures (Supplementary Figure 4D and 4E), consistent with our previous
finding that the SBD is not required for OSBP colocalization with NS5A.
The dependence of RNA viruses on OSBP correlates with their dependence on PI 4-
kinases
Like HCV, Dengue virus (DENV) is also a flavivirus, but its replication does not require
PI4KA32. Silencing of PI4KA, PI4KB, or OSBP failed to substantially inhibit replication of
a DENV replicon (Figure 7A). Consistent with these results, the PI4KA inhibitor AL-9 and
the OSBP inhibitor OSW-1 had only minor effects on DENV replication (Figure 7B) at
concentrations that strongly inhibit HCV replication (Figure 1C and Supplementary Figure
5). These results suggest that DENV replication is not dependent on PI4KA, PI4KB, or
OSBP.
Conversely, poliovirus (PV) is a positive-sense RNA virus that exploits the PI 4-kinase
PI4KB for its replication17. Three independent OSBP shRNAs inhibited PV infection in
HeLa cells (Figure 7C). We conclude that the dependence of three RNA viruses on OSBP
correlates with their dependence on PI 4-kinases, supporting a link between PI 4-kinases and
OSBP in RNA virus infection.
DISCUSSION
Although PI 4-kinases and PI(4)P have been implicated in positive sense RNA virus-
induced remodeling of intracellular membranes8,9,14,16,17, their effectors in this process have
not been defined. In this study, we identify OSBP as a PI4KA effector in the formation of
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the HCV membranous web. While HCV exploits PI4KA for its replication, several
picornaviruses instead depend on the related PI 4-kinase PI4KB17,18,33. The utilization of
two different PI 4-kinases by RNA viruses suggests a common requirement for PI(4)P, and
possibly also for common cellular PI(4)P effectors. Consistent with this hypothesis, we find
that OSBP appears to be a cofactor for poliovirus replication, even though PV exploits
PI4KB rather than PI4KA. Conversely, DENV does not require PI4KA, PI4KB, or OSBP
for its replication. If these findings are extended to other RNA viruses, then inhibition of PI
4-kinase effectors may be a potential broadly antiviral strategy.
Non-vesicular intracellular cholesterol trafficking in mammalian cells has been proposed to
be regulated by lipid transfer proteins such as OSBP. However, there has been little
evidence that OSBP can regulate cholesterol trafficking in mammalian cells. Here we find
that cholesterol trafficking to the HCV membranous web is regulated by OSBP and that it
functions downstream of PI4KA. We propose that recruitment of PI4KA to the membranous
web and its activation by HCV NS5A9 leads to the local accumulation of PI(4)P. OSBP
recruitment to the web by PI(4)P and possibly also by VAPs, which are also enriched at
webs and interact with HCV NS5A34,35, then stimulates the delivery of cholesterol to the
web, possibly by exchanging cholesterol with PI(4)P30,31. This is consistent with the
requirement of the PH domain, the FFAT domain, the sterol-binding domain, and PI(4)P-
interacting residues within the SBD for OSBP to support HCV replication. Although intact
membranous webs have not been isolated from HCV-infected cells at sufficient purity to
permit direct measurement of their lipid composition, a recent study has shown that affinity-
purified NS4B-enriched membranes from HCV-infected cells are cholesterol-enriched, and
also found that cholesterol depletion could inhibit HCV replication6.
In addition to cholesterol transport, OSBP regulates sphingomyelin synthesis at the Golgi by
stimulating the recruitment of ceramide transfer protein36. Lipid raft membranes are also
enriched in sphingomyelin and glycophingolipids, and inhibitors of sphingolipid synthesis
suppress HCV replication37. Our results do not exclude the possibility that PI4KA and
OSBP also regulate the accumulation of sphingolipids at the membranous web, although we
have not observed efficient trafficking of fluorescent sphingolipids to webs (not shown).
We do not know why HCV replication might be dependent on cholesterol and/or
sphingolipid enrichment at the membranous web. Possibilities include alteration of
membrane fluidity or curvature, recruitment of cellular or viral factors necessary for viral
replication, and direct stimulation of viral enzymatic activity by binding to sterols and/or
sphingolipids38. The development of systems to reconstitute HCV genome replication in
vitro from purified components would greatly facilitate our ability to discriminate among
these alternatives.
Materials and Methods
Additional methods are described in Supplementary Material.
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Viruses and viral replicons
The genotype 2a HCV strain JFH-1 was produced and propagated as described in 39. A
subgenomic replicon expressing mCherry-tagged NS5A based on the JFH-1 genotype 2a
sequence, termed here as pSGR-JFH1(NS5A/mCherry) and a dengue virus replicon based
on the DENV-2 16681 strain with a Renilla luciferase reporter gene are described in
Supplemental information. Poliovirus (PV) used in this study is type 1 Mahoney.
Immunofluorescence staining
Immunofluorescent staining was performed as described in 15. PI(4)P staining of
intracellular membranes was performed exactly as described in 40. A Nikon A1 laser
scanning confocal microscope was used with sequential scanning mode to limit crosstalk
between fluorochromes. PI(4)P fluorescence intensity was quantified using ImageJ software
from multiple random fields obtained with identical acquisition settings.
Subcellular fractionation
Huh7.5.1 cells were infected with JFH-1 (MOI = 0.1) and cells were harvested at 5 days
postinfection. For AL-9 or OSW-1 treatment, Huh7.5.1 cells were infected 4 days prior to
drug treatment for 4 hr before harvesting. DRM isolation was performed as described
previously41, and described further in Supplementary Material.
TopFluor-cholesterol cell labeling
Huh7.5.1 cells stably transduced with nontargeting, PI4KA, or OSBP shRNA were infected
with JFH-1 (MOI = 0.1). 4 days later, TopFluor-Cholesterol (TF-cholesterol; Avanti Polar
Lipids, Alabaster, AL) was added to the culture medium to a final concentration of 2 μM for
2 hr before they were immunolabeled for NS5A. Drug treatment with OSW-1 or AL-9 was
performed before the addition of TF-Cholesterol. TF-cholesterol labeled replicon cells
underwent live-cell imaging, while HCV-infected cells underwent subcellular fractionation.
The fluorescence intensity of TF-cholesterol in the collected fractions was measured with a
Synergy2 plate reader equipped with 485±20 nm excitation and 520±25 nm emission filters.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations used in this paper
DMV double-membrane vesicle
DRM detergent-resistant membrane
FFAT two phenylalanines in an acidic tract
HCV hepatitis C virus
MMV multi-membrane vesicle
ORP OSBP-related protein
OSBP oxysterol-binding protein
PH pleckstrin homology
PI phosphatidylinositol
PI(4)P phosphatidylinositol 4-phosphate
SBD sterol-binding domain
TF TopFluor
VAP vesicle-associated membrane protein-associated protein
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Figure 1. OSBP is relevant to HCV replication
(A) OR6 replicon cells were transduced with the indicated shRNAs. 72 hr later, replication
and cell viability were assessed by Renilla luciferase activity and cellular ATP content,
respectively (left panel). Right panel, immunoblotting of cell lysates. Values (means ± SEM,
three independent experiments) are normalized to a nontargeting shRNA. **, P<.001 versus
nontargeting control.
(B) Huh7.5.1 cells were transduced with the indicated shRNAs 72 hr before infection with
the JFH-1 strain of HCV (MOI = 0.1). HCV and OSBP mRNA were quantified by qRT-
PCR at 48 hr postinfection (left panel). Right panel, immunoblotting of cell lysates. Values
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(means ± SD, three independent experiments) are normalized to nontargeting shRNA. *, P<.
005 versus nontargeting control.
(C) OR6 cells were treated with OSW-1 for 24 hr prior to measurement of HCV replication
and cell viability (left panel). Right panel, immunoblotting of cell lysates. Values are means
± SEM, three independent experiments.
(D) OR6 cells stably expressing a nontargeting shRNA or an OSBP shRNA targeting the
3′UTR were transduced with lentiviral vectors encoding the indicated HA-tagged OSBP
constructs lacking the 3′UTR. Luciferase activity was measured 4 days later (left panel).
Right panel, immunoblotting of cell lysates. Values are mean ± SEM of three independent
experiments and are normalized to nontargeting control. **, P<.001 versus nontargeting
control.
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Figure 2. OSBP localizes to membranous webs
(A) Immunostaining of JFH-1 infected cells for NS5A (green) and endogenous OSBP (red)
with DAPI nuclear counterstaining (blue). Manders’ coefficients: M1=0.60 (fraction of
NS5A overlapping OSBP); M2=0.07 (fraction of OSBP overlapping NS5A). Bar, 10 μm.
(B) Uninfected or HCV-infected Huh7.5.1 cell homogenates (H) were centrifuged to prepare
a crude membrane pellet and a “water soluble” supernatant (WS). The pellet was treated
with cold 1% NP-40 and spun again; the “detergent soluble” (DS) fraction was removed and
detergent-resistant membranes were fractionated on a density gradient. Fractions (numbered
in order from light to heavy) were analyzed by immunoblotting for the indicated proteins.
(C) Immunoblots of homogenates from uninfected or HCV-infected Huh7.5.1 cells, treated
with or without cold 1% NP-40 followed by treatment with or without proteinase K (PK).
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Figure 3. OSBP or PI4KA inhibition alters membranous web morphology
(A) HCV-infected Huh7.5.1 cells stably transduced by nontargeting, PI4KA, or OSBP
shRNA were immunostained for HCV NS5A (green) with DAPI nuclear counterstaining
(blue).
(B) HCV-infected cells were treated with 0.1% DMSO or 30 nM OSW-1 for 24 hr before
NS5A immunostaining. Bar, 10 μm.
(C) HCV-infected cells were treated with 0.1% DMSO, 4 μM AL-9, or 20 nM OSW-1 for
18 hr before preparation for EM. Enlargements of the boxed areas are shown in the right
panels; values are DMV mean diameter ± SD. Arrowheads: double-membrane vesicles
(DMVs); Arrows: multi-membrane vesicles (MMVs); LD: lipid droplets; ER: endoplasmic
reticulum; mt: mitochondria; N, nucleus.
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Figure 4. OSBP inhibition alters web morphology without blocking HCV-induced PI(4)P
accumulation
(A) Nonreplicative expression of the NS3-5B(NS5A/GFP) polyprotein in Huh7.5.1/T7 cells
stably expressing T7 RNA polymerase and the indicated shRNAs. 48 hr post-transfection,
cells were immunostained for PI(4)P (red) and GFP (green) with DAPI nuclear
counterstaining (blue). Arrowheads indicate cells expressing the NS3-5B/GFP polyprotein.
Bar, 20 μm.
(B) Quantitation of PI(4)P fluorescence from HCV-expressing cells (open symbols) versus
HCV-nonexpressing cells (closed symbols). Each point denotes the integrated fluorescence
signal from a single cell with the mean fluorescence indicated by the black lines.
(C) Immunostaining of JFH-1 infected Huh7.5.1 cells stably expressing the indicated
shRNAs for PI(4)P (red) and GFP (green) with DAPI nuclear counterstaining (blue). Pr,
Pearson’s correlation coefficients; bar, 10 μm.
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Figure 5. OSBP localization to membranous web requires PI4KA activity
(A) The NS3-5B(NS5A/GFP) polyprotein was expressed in Huh7.5.1/T7 cells stably
expressing a nontargeting or a PI4KA shRNA. 48 hr post-transfection, cells were
immunostained for OSBP (red) and NS5A (green) with DAPI nuclear counterstaining
(blue). M1 and M2, Manders’ coefficients; M1 represents the fraction of NS5A overlapping
OSBP. Bar, 10 μm.
(B) The NS3-NS5B(NS5A/GFP) polyprotein was expressed in Huh7.5.1/T7 cells. 48 hr
later, cells were treated with 0.1% DMSO or 4 μM AL-9 for 24 hr, and then immunostained
for NS5A (green) and endogenous OSBP (red) with DAPI nuclear counterstaining (blue).
M1 and M2, Manders’ coefficients; M1 represents the fraction of NS5A overlapping OSBP.
Bar, 10 μm.
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Figure 6. Cholesterol depletion inhibits HCV replication, and cholesterol trafficking to
membranous webs requires PI4KA and OSBP
(A) OR6 cells were treated with the indicated concentrations of MβCD or MβCD-
cholesterol complexes for 4 hr, washed, and then incubated for 24 hr prior to measurement
of luciferase activity (left panel), cellular cholesterol content (middle panel), and
immunoblotting (right panel). Values (means ± SEM, three independent experiments) are
normalized to control. **, P<.001 versus control.
(B) HCV-infected Huh 7.5.1 cells stably expressing the indicated shRNAs were labeled with
2 μM TopFluor-cholesterol (green) for 2 hr followed by immunostaining for NS5A (red)
with DAPI nuclear counterstaining (blue). Pr, Pearson’s correlation coefficients; bar, 10 μm.
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(C, D) Live-cell imaging of cells stably expressing a subgenomic replicon with mCherry-
tagged NS5A (red) treated with 0.1% DMSO (left panels), 4 μM AL-9 (C, right panels), or
30 nM OSW-1 (D, right panels) for 8 hr before labeling with 2 μM TF-cholesterol (green)
for another 16 hr. Pr, Pearson’s correlation coefficients; bar, 10 μm.
(E) Upper panel: Uninfected (solid line) or HCV-infected (dotted line) cells were labeled
with 2 μM TF-cholesterol for 4 hr; Lower panel: JFH-1 infected cells were treated with
0.1% DMSO (red), 5 μM AL-9 (green), or 50 nM OSW-1 (blue) for 4 hr in the presence of 2
μM TF-cholesterol. Cell homogenates were then fractionated as in Figure 2B. Fluorescence
intensity of TF-cholesterol was measured from each fraction and represented as a percentage
of the total TF-cholesterol fluorescence in all fractions. Values are mean ± SEM, four
independent experiments. Inset, immunoblotting of total cell homogenates.
(F) OR6 cells stably expressing the indicated shRNAs were transduced with lentiviral
vectors encoding HA-OSBP constructs lacking the 3′UTR, followed 4 days later by
luciferase activity measurement (upper panel) and immunoblotting (lower panel). Values
(mean ± SEM, four independent experiments) are normalized to nontargeting control. **,
P<.001 versus nontargeting control.
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Figure 7. The dependence of RNA viruses on OSBP correlates with their dependence on PI 4-
kinases
(A) Huh7.5.1 cells containing a subgenomic DENV replicon expressing a Renilla luciferase
reporter were transduced with the indicated shRNAs for 72 hr prior to luciferase activity
measurement (left panel) and immunoblotting (right panel). Values (means ± SD, two
independent experiments) are normalized to control cells
(B) DENV replicon cells were treated with the indicated concentrations of OSW-1 (left
panel) or AL-9 (right panel) for 24 hr before luciferase activity measurement. Values are
means ± SD, two independent experiments.
(C) HeLa cells stably expressing a nontargeting shRNA or three independent OSBP shRNAs
were infected with poliovirus (MOI 0.1) 24 hr before measurement of viral titers (left panel),
and immunoblotting (right panel). *, P = .004 and **, P< .001 versus nontargeting shRNA.
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